Brief: Rhythm Biosciences Says Market Entry Of Colostat Into United Kingdom
24/05/2023 02:01
May 24 (Reuters) - Rhythm Biosciences Ltd RHY.AX :
* MARKET ENTRY OF COLOSTAT INTO UNITED KINGDOM POST APPROVAL
OF
UKCA MARK CERTIFICATION
* SIGNED A STRATEGIC PARTNERSHIP WITH LINK MEDICAL SOLUTIONS
* STRATEGIC PARTNERSHIP WILL PROVIDE RHYTHM WITH A PHASED
APPROACH
TO SUCCESSFUL MARKET ENTRY IN UK
Source text for Eikon: ID:nASXWyxkN
Further company coverage: RHY.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rhythm Biosciences
See all newsBrief: Rhythm Biosciences Says Gavin Fox-Smith Resigns As Chair
Brief: Rhythm Biosciences Announces Appointment Of Non-Executive Directors
Australia's Rhythm Biosciences rises on accelerating commercialisation of cancer test
Brief: Rhythm Biosciences Executes Distribution Agreement For Genetype
Brief: Rhythm Biosciences Seeks Trading Halt